The United Kingdom National External Quality Assessment Scheme (blood transfusion laboratory practice): trends in proficiency and practice between 1985 and 2000

被引:21
作者
Knowles, SM
Milkins, CE
Chapman, JF
Scott, M
机构
[1] UK NEQAS BTLP, Watford WD1 8WP, England
[2] Barts & London NHS Trust, London, England
[3] Int Blood Grp Reference Lab, Bristol, Avon, England
关键词
blood group serology; blood transfusion laboratory practice; external quality assessment; UKNEQAS;
D O I
10.1046/j.1365-3148.2002.00353.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Proficiency in blood transfusion laboratory practice has improved over the last 15 years (1985-2000). Error rates for ABO grouping have fallen from 0.19 to 0.02% (P = 0.003). A similar trend is evident for antibody screening, with error rates for false negative antibody screens falling from 3.2 to 0.5% (P < 0.001), and for antibody identification, for sera containing a single alloantibody, with error rates falling from 8.8% to 0.9% over the last 10 years (P < 0.001). Proficiency in serological crossmatching to detect clinically significant non-ABO incompatibilities (other than Kidd), has also improved (P < 0.001). However, error rates for RhD grouping have not changed and there has been a recent decline in proficiency in detecting weak ABO incompatibilities and Kidd antibodies with heterozygous cells. Procedures for pretransfusion testing have also been rationalized over this time. The indirect antiglobulin test (IAT) is used in isolation by 73% of laboratories for antibody screening, and 10% rely on the direct room temperature (DRT), immediate spin (IS) crossmatch in the absence (current and/or historical) of clinically significant antibodies. Despite the improvements in error rates that have occurred alongside the rationalizations, there is still evidence of noncompliance with current published BCSH guidelines and manufacturers' instructions.
引用
收藏
页码:11 / 23
页数:13
相关论文
共 26 条
[1]  
Ashford P, 2000, TRANSFUSION MED, V10, P307
[2]   LIMITATIONS OF THE IMMEDIATE SPIN CROSSMATCH WHEN USED FOR DETECTING ABO INCOMPATIBILITY [J].
BERRYDORTCH, S ;
WOODSIDE, CH ;
BORAL, LI .
TRANSFUSION, 1985, 25 (02) :176-178
[3]  
Chapman JF, 1999, TRANSFUSION, V39, p95S
[4]   Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories [J].
Chapman, JF ;
Forman, K ;
Kelsey, P ;
Knowles, SM ;
Murphy, MF ;
Wood, JK ;
Baglin, T ;
Milkins, CE ;
Poole, G .
TRANSFUSION MEDICINE, 1996, 6 (03) :273-283
[5]   A prospective study of routine antenatal enzyme antibody screening demonstrates lack of clinical value in predicting haemolytic disease of the newborn [J].
Clark, D ;
Greiss, MA ;
Urbaniak, SJ .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 106 (03) :824-826
[6]   FAILURE OF DIAMED-ID MICROTYPING SYSTEM TO DETECT MAJOR ABO INCOMPATIBILITY [J].
CUMMINS, D ;
DOWNHAM, B .
LANCET, 1994, 343 (8913) :1649-1650
[7]  
HOLBURN AM, 1988, CLIN LAB HAEMATOL, V10, P73
[8]  
HOLBURN AM, 1982, CLIN LAB HAEMATOL, V4, P155
[9]  
HOLBURN AM, 1987, CLIN LAB HAEMATOL, V9, P33
[10]   THE UK NATIONAL EXTERNAL QUALITY ASSESSMENT SCHEME IN BLOOD-GROUP SEROLOGY - ABO AND D-GROUPING AND ANTIBODY SCREENING 1982-1983 [J].
HOLBURN, AM ;
PRIOR, D .
CLINICAL AND LABORATORY HAEMATOLOGY, 1986, 8 (03) :243-256